Commentary: The pros and cons of essential medicines for rich countries

被引：3
|
作者：
Reidenberg, MM
Walley, T
机构：
[1] Cornell Univ, Weill Med Coll, New York, NY 10021 USA
[2] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3GF, Merseyside, England
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2004年 / 329卷 / 7475期
关键词：
D O I：
10.1136/bmj.329.7475.1172
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1172 / 1172
页数：1
相关论文
共 50 条
  • [31] DIFFERENCES OF APPLICATION PART-TIME IN EU COUNTRIES, PROS AND CONS
    Wojcak, Emil
    Barath, Matus
    MANAGEMENT AND ECONOMICS IN MANUFACTURING, 2017, : 74 - 81
  • [32] HOW TO IMPLEMENT NATIONAL ESSENTIAL MEDICINE LIST IN SHANGHAI: PROS & CONS
    Hu, S.
    Zhang, Y. B.
    He, J.
    VALUE IN HEALTH, 2010, 13 (03) : A218 - A218
  • [33] Essential tuberculosis medicines and health outcomes in countries with a national essential medicines list
    Maraj, Darshanand
    Steiner, Liane
    Persaud, Nav
    JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2022, 27
  • [34] SCHENGEN - THE PROS AND CONS
    不详
    COMMON MARKET LAW REVIEW, 1995, 32 (03): : 673 - 678
  • [35] IBM - PROS AND CONS
    FITZGIBBON, B
    POPULAR COMPUTING, 1984, 3 (09): : 14 - 14
  • [36] COGENERATION PROS/CONS
    PHILLIPS, CW
    ASHRAE JOURNAL-AMERICAN SOCIETY OF HEATING REFRIGERATING AND AIR-CONDITIONING ENGINEERS, 1990, 32 (09): : 14 - 14
  • [37] Pros and cons of centralization
    不详
    NATURE, 2003, 423 (6942) : 787 - 787
  • [38] Pros and cons of ERPs
    不详
    CONTROL AND INSTRUMENTATION, 1998, 30 (12): : 27 - 27
  • [39] Pros and cons of dabigatran
    Cheng, Christine M.
    McCurdy, Megan R.
    Wong, Heather A.
    Kayser, Steven R.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (16) : 1495 - 1495
  • [40] Circumcision pros and cons
    Brockmeyer, N. H.
    HAUTARZT, 2010, 61 (02): : 171 - 171
12345